Gilead’s Bixlenvo becomes the first single-tablet HIV option for suppressed patients on multi-pill regimens.
HHS eyes new FDA deputy roles for technology including AI and for drugs, with Jared Seehafer leading the tech candidate list under nominee Heidi Overton.
